Sphera Funds Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200,000
Closed -$1.92M 93
2022
Q2
$1.92M Buy
+200,000
New +$2.51M 0.21% 42

Sphera Funds Management's ISEE Position: Q3 2023 in Review

Sphera Funds Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 134,414 shares — an estimated $5.29M sold.

Sphera Funds Management first reported a position in ISEE in Q4 2019 and held it in 12 quarters. The position peaked at $13M in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Sphera Funds Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Sphera Funds Management sold 134,414 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.29M.
  • Sphera Funds Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Sphera Funds Management's IVERIC bio, Inc. Common Stock position peaked at $13M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.